TISSUE & FFPE COHORT COLLECTIONS
Melanoma tissue microarrays & FFPE blocks
Explore melanoma arrays by tissue composition and treatment setting, including selected immunotherapy-follow-up collections. For FFPE blocks, share your tissue and study requirements with our team.
THE ARRAYS
Melanoma arrays (15)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
Cutaneous melanoma (III-IV) & Uveal mealnoma (II-IV) with histopath & optional follow up data (TA4306)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Optional follow-up listed
- Marker & molecular data
- Not listed
IO Multi tumor array 3 of a set of 6 TMAs : Sarcoma, GIST, Gallbladder, Head & Neck SCC, Melanoma, GBM, Thyroid with histopath data. 1x1mm core each from tumor & invasive edge (TA3126)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
IO Multi tumor array 3 of a set of 6 TMAs : Sarcoma, GIST, Gallbladder, Head & Neck SCC, Melanoma, GBM, Thyroid with histopath data. 1x1mm core each from tumor & invasive edge (TA4440)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Malignant melanoma (III_IV) & melanoma mets with 1st & 2nd line IO treatment follow up & optional RNAseq data (TA4317)
- Approx. cores
- 44
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Optional datasets listed; review coverage
Malignant melanoma pre treatment & post treatment (not donor matched) with follow up data (TA3154)
- Approx. cores
- 44
- Approx. donors
- 22
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Melanoma TMA with IO follow up data, includes pre-IO & post IO treatment samples (not donor matched) (TA4385)
- Approx. cores
- 80
- Approx. donors
- 80
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
Metastatic Melanoma (III/IV) primary, mets with follow up data including 1st line chemo & 2nd line IO treatment (TA2925)
- Approx. cores
- 50
- Approx. donors
- 50
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
Multi tumor array 2 of a set of 4 TMAs : Pancreatic, Ovarian, Gastric, Head & Neck SCC, Melanoma, Bladder (UC) with histopath data (TA2996)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising breast, bladder(uc), ovarian, lung, prostate, melanoma, RCC , head & neck SCC, CRC, pancreatic ADC with histopath data (TA4340)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising cores with high immune infiltrates from Pancreatic, Melanoma, Breast, HCC & CRC. TMA2 of a set of 2 TMAs, histopath data (TA4313)
- Approx. cores
- 120
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi Tumor Tissue Array – with histopath data – NHL, bladder (UC), melanoma, head & neck SCC, endometrial (TA1788-1)
- Approx. cores
- 140
- Approx. donors
- 70
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Primary melanoma stages I & II with survival data (TA4336)
- Approx. cores
- 36
- Approx. donors
- 18
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array 120 cores total, 1mm core diameter – (same as previous TA4380) (TA4388)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array, 2mm core diameter, TMA2 of a set of 2 TMAs, histopath data (TA3118)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
tumor & invasive edge cores/donor, sarcoma, GIST, biliary ADC, Head & Neck SCC, melanoma, GBM, thyroid (TA3110)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Melanoma FFPE blocks for your study
Melanoma cohorts with treatment and follow-up information, including explicitly unmatched pre/post-treatment groups.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
FFPE TISSUE COHORTS
Melanoma FFPE cohorts
Select a cohort or patient profile, then share your sample and data requirements with our team.
Cohort #140
Cutaneous melanoma (III-IV) & Uveal melanoma (II-IV) with histopath & optional follow up data
Cohort #141
Malignant melanoma (III/IV) & melanoma mets with 1st & 2nd line IO treatment follow up data
Cohort #142
Malignant melanoma pre treatment & post treatment (not donor matched) with follow up data
Cohort #143
Melanoma with IO follow up data, includes pre-IO & post IO treatment samples (not donor matched)
Cohort #144
Metastatic Melanoma (III/IV) primary, mets with follow up data including 1st line chemo & 2nd line IO treatment
Cohort #145
Primary melanoma stages I & II with survival data
Melanoma · Patient profile
Resectable stage III/IV melanoma
Melanoma · Patient profile
Before or after immunotherapy / checkpoint inhibitor treatment
SELECTING YOUR ARRAY
Selecting melanoma tissue for your study
Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.
TA2925 tissue composition
Metastatic Melanoma (III/IV) primary, mets with follow up data including 1st line chemo & 2nd line IO treatment (TA2925).
TA3154 tissue composition
Malignant melanoma pre treatment & post treatment (not donor matched) with follow up data (TA3154).
TA4306 tissue composition
Cutaneous melanoma (III-IV) & Uveal mealnoma (II-IV) with histopath & optional follow up data (TA4306).










